Additional Information
Market:ASX
Sector:General Mining
EPIC:AEE
Latest Price: 0.15  (0.00%)
52-week High:0.34
52-week Low:0.13
Market Cap:22.39M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Aura Energy Full Aura Energy profile here

Aura Energy (ASX: AEE) is a uranium explorer with advanced projects in Sweden, West Africa and Australia. The company is focusing on two main projects: the Storsjön Project located in Sweden’s Alum Shale Province, one of the largest depositories of uranium in the world; and the highly prospective Reguibat Project in Mauritania. 

 

Aura Energy’s main projects in Sweden are based on the Alum Shales, which have been historically known as one of the largest depositories of uranium in the world. Aura Energy has exploration permits and applications in three regions in west Africa: the Reguibat Craton in Mauritania, the Mauritanide Fold belt in Mauritania, and the Tim Mersoi Basin in Niger.

Pdf

Aura Energy to commence stage 2 bioleaching at Häggån project in Sweden

Monday, November 29, 2010
Aura Energy to commence stage 2 bioleaching at Häggån project in Sweden

With positive results from stage 1, Aura Energy (ASX: AEE) has commissioned stage 2 which includes testing using bioleach technology for the extraction of uranium and other metals from the Häggån project, located in Sweden’s Alum Shale Province, one of the largest uranium deposits in the world.

The aim of the work is to determine the optimal process route for Aura’s giant uranium deposit at the Häggån project, in order to secure enhanced extraction of uranium, molybdenum and nickel from the Alum Shale.

This next stage will work with larger samples, a range of acidities and will test agglomeration as a means of enhancing permeability.

Bob Beeson, managing director, said “This next stage of work is built on the encouraging results of stage 1 and is another step closer to choosing an extraction method for uranium and other metals found within the Häggån project."

The company prefers the bioleach technology approach as capital and operating costs can be low in comparison with other technologies.

Preparatory work is expected to be completed in January with all bioleaching results expected by June 2011.

 

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.